Literature DB >> 4975059

Light chain homogeneity of post-infective cold agglutinins.

T Feizi, M Schumacher.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4975059      PMCID： PMC1579019     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  21 in total

1.  [THE COLD AGGLUTININ SYNDROME].

Authors:  K LIND
Journal:  Ugeskr Laeger       Date:  1963-11-15

2.  Eaton agent pneumonia-clinical features.

Authors:  M A MUFSON; M A MANKO; J R KINGSTON; R M CHANOCK
Journal:  JAMA       Date:  1961-10-28       Impact factor: 56.272

3.  Methyldopa and haemolytic anaemia.

Authors:  H A Wurzel; J L Silverman
Journal:  Lancet       Date:  1966-05-21       Impact factor: 79.321

4.  Electrophoretic analysis of polypeptide chains isolated from antibodies in the serum of immunized rabbits.

Authors:  E J Miller; C K Osterland; J M Davie; R M Krause
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

5.  Cold agglutinin anti-I and Mycoplasma pneumoniae.

Authors:  T Feizi; D Taylor-Robinson
Journal:  Immunology       Date:  1967-10       Impact factor: 7.397

6.  Light-chain heterogeneity of cold agglutinins.

Authors:  N Costea; V Yakulis; P Heller
Journal:  Science       Date:  1966-06-10       Impact factor: 47.728

7.  Light chain types of transiently occurring cold haemagglutinins.

Authors:  M Harboe; K Lind
Journal:  Scand J Haematol       Date:  1966

8.  Exclusive occurrence of K chains in isolated cold haemagglutinins.

Authors:  M Harboe; R van Furth; H Schubothe; K Lind; R S Evans
Journal:  Scand J Haematol       Date:  1965

9.  Lambda chains in cold agglutinins.

Authors:  T Feizi
Journal:  Science       Date:  1967-05-26       Impact factor: 47.728

10.  STUDIES ON HUMAN ANTIBODIES. I. STARCH GEL ELECTROPHORESIS OF THE DISSOCIATED POLYPEPTIDE CHAINS.

Authors:  G M EDELMAN; E A KABAT
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307
View more
  10 in total

1.  Two cases of monoclonal immunoglobulins with antistreptolysin activity: clinical and laboratory study.

Authors:  F A Lustermans; F Klein
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

2.  Immunochemical studies on blood groups. LIV. Classification of anti-I and anti-i sera into groups based on reactivity patterns with various antigens related to the blood group A,B,H, Le a, Le b and precursor substances.

Authors:  T Feizi; E A Kabat
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

3.  A common idiotype on human macroglobulins with anti-I and anti-i specificity.

Authors:  J Lecomte; T Feizi
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

4.  Blood group antigens. Ii antigens.

Authors:  T Feizi
Journal:  Proc R Soc Med       Date:  1975-12

5.  Light chain sequences of human IgM cold agglutinins (variable-region subgroups amino-acid sequence-kappa light chain-N-terminal).

Authors:  J D Capra; J M Kehoe; R C Williams; T Feizi; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

6.  Kappa:lambda light chain ratio in IgG eluted from rheumatoid arthritis synovium.

Authors:  F D Lindström
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

7.  Progress in deciphering the information content of the 'glycome'--a crescendo in the closing years of the millennium.

Authors:  T Feizi
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

8.  [High titer cold agglutinins with anti-pr specificity after rubella infection (author's transl)].

Authors:  H P Geisen; D Roelcke; K Rehn; G Konrad
Journal:  Klin Wochenschr       Date:  1975-08-15

Review 9.  [Cold agglutinin disease].

Authors:  R G Geissler; J Köbberling
Journal:  Klin Wochenschr       Date:  1988-04-01

10.  Immunochemical studies on blood groups. XLVII. The I antigen complex--precursors in the A, B, H, Lea, and leb blood group system--hemagglutination-inhibition studies.

Authors:  T Feizi; E A Kabat; G Vicari; B Anderson; W L Marsh
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.